Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  The Pakistan Stock Exchange  >  Abbott Laboratories (Pakistan) Limited    ABOT   PK0025701019

ABBOTT LABORATORIES (PAKISTAN) LIMITED

(ABOT)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Re-appointment of Chief Executive of Abbott Laboratories Limited

share with twitter share with LinkedIn share with facebook
05/29/2020 | 09:43am EDT

Abbott Laboratories Limited informed Pakistan Stock Exchange that Syed Anis Ahmed has been re-appointed as the Chief Executive of the Company for a term of 3 years commencing on May 28, 2020.

The announcement is available at:

https://dps.psx.com.pk/download/document/148347.pdf

Abbott Laboratories Limited is a public limited company. It was incorporated in Pakistan on July 2, 1948. Abbott started operations in Pakistan as a marketing affiliate in 1948. The company is engaged in the manufacturing, importing and marketing of research based pharmaceutical, nutritional, diagnostic, diabetic care, molecular devices, and hospital and consumer products. The company also provides toll manufacturing services. The stocks of the company are quoted on the Karachi, Lahore and Islamabad stock exchanges of Pakistan. The registered office of the company is located in Karachi.

Abbott Pakistan is part of the global healthcare corporation of Abbott Laboratories, Chicago, USA. It has over 70,000 employees worldwide and a global presence in more than 130 countries. It has a work force of over 1500 employees. Besides this the company has two manufacturing facilities located at Landhi and Korangi in Karachi.

The symbol "ABOT" is being used by the stock exchanges for the shares of Abbott Laboratories Limited.

© Pakistan Press International, source Asianet-Pakistan

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 0.64% 92.23 Delayed Quote.6.18%
ABBOTT LABORATORIES (PAKISTAN) LIMITED -1.42% 637.63 End-of-day quote.42.72%
PAKISTAN STOCK EXCHANGE LIMITED -0.61% 9.79 End-of-day quote.-21.55%
share with twitter share with LinkedIn share with facebook
Latest news on ABBOTT LABORATORIES (PAKIS
06/11Credit of Final Cash Dividend of Abbott Laboratories Limited
AQ
06/04Transaction of 7,000 shares of Attock Cement Pakistan Limited
AQ
06/01Transmission of Quarterly Report for the Period Ended March 31, 2020 of Abbot..
AQ
05/29Transmission of Quarterly Report for the Period Ended March 31, 2020 of Abbot..
AQ
05/29Re-appointment of Chief Executive of Abbott Laboratories Limited
AQ
05/29Re-appointment of Chairman of Abbott Laboratories Limited
AQ
05/29Financial results of Abbott Laboratories Limited for Quarter ended March 31, ..
AQ
05/28Election of Directors of Abbott Laboratories Limited
AQ
05/28Board of directors meeting of Abbott Laboratories Limited
AQ
05/28Board Meeting in Progress of Abbott Laboratories Limited
AQ
More news
Financials
Sales 2019 30 156 M 180 M 180 M
Net income 2019 1 300 M 7,74 M 7,74 M
Net cash 2019 2 376 M 14,1 M 14,1 M
P/E ratio 2019 33,6x
Yield 2019 1,68%
Capitalization 62 525 M 373 M 372 M
EV / Sales 2018 1,89x
EV / Sales 2019 1,37x
Nbr of Employees 1 540
Free-Float 100%
Chart ABBOTT LABORATORIES (PAKISTAN) LIMITED
Duration : Period :
Abbott Laboratories (Pakistan) Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES (PAKIS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers
NameTitle
Syed Anis Ahmed Chief Executive Officer & Executive Director
Munir Ahmad Shaikh Chairman
Ihsan Ullah Khan Khattak Operations Director
Syed Tabish Aseem Chief Financial Officer
Raeef Ahmed Director-Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES (PAKISTAN) LIMITED42.72%372
JOHNSON & JOHNSON-3.36%371 399
ROCHE HOLDING AG6.02%299 393
MERCK & CO., INC.-13.38%198 849
NOVARTIS AG-9.64%193 542
PFIZER, INC.-11.92%191 697